User profiles for Young-Sook Kang

Young-Sook Kang

숙명여자대학교 약학부 교수
Verified email at sookmyung.ac.kr
Cited by 5555

Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood–brain barrier …

WM Pardridge, YS Kang, JL Buciak, J Yang - Pharmaceutical research, 1995 - Springer
Purpose. The ability of monoclonal antibodies against the human insulin receptor to undergo
transcytosis through the blood-brain barrier (BBB) was examined in the present studies. …

Anti-inflammatory activity of Taraxacum officinale

HJ Jeon, HJ Kang, HJ Jung, YS Kang, CJ Lim… - Journal of …, 2008 - Elsevier
Taraxacum officinale has been widely used as a folkloric medicine for the treatment of diverse
diseases. The dried plant was extracted with 70% ethanol to generate its ethanol extract (…

Transport of Human Recombinant Brain-Derived Neurotrophic Factor (BDNF) Through the Rat Blood−Brain Barrier in Vivo Using Vector-Mediated Peptide Drug …

WM Pardridge, YS Kang, JL Buciak - Pharmaceutical research, 1994 - Springer
The blood–brain barrier (BBB) transport of brain-derived neurotrophic factor (BDNF) in
anesthetized rats was examined in the present studies using vector-mediated peptide drug …

Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice

IY Kim, YS Kang, DS Lee, HJ Park, EK Choi… - Journal of Controlled …, 2009 - Elsevier
Immunoliposomes directed by monoclonal antibodies are promising vehicles for tumor targeted
drug delivery. Development of a long-circulating formulation of pH-sensitive liposomes (…

Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia

AK Kumagai, YS Kang, RJ Boado, WM Pardridge - Diabetes, 1995 - Am Diabetes Assoc
An in vivo model of chronic hypoglycemia was used to investigate changes in blood-brain
barrier(BBB) glucose transport activity and changes in the expression of GLUT1 mRNA and …

Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells

…, S Ohtsuki, T Deguchi, YS Kang… - Journal of Cerebral …, 2003 - journals.sagepub.com
The mechanism that removes homovanillic acid (HVA), an end metabolite of dopamine, from
the brain is still poorly understood. The purpose of this study is to identify and characterize …

Vector-mediated delivery of a polyamide (" peptide") nucleic acid analogue through the blood-brain barrier in vivo.

…, RJ Boado, YS Kang - Proceedings of the …, 1995 - National Acad Sciences
Polyamide ("peptide") nucleic acids (PNAs) are molecules with antigene and antisense
effects that may prove to be effective neuropharmaceuticals if these molecules are enabled to …

Brain microvascular and astrocyte localization of P‐glycoprotein

WM Pardridge, PL Golden, YS Kang… - Journal of …, 1997 - Wiley Online Library
The hypothesis that P‐glycoprotein plays a functional role at the brain capillary endothelium,
which makes up the blood‐brain barrier in vivo, is based largely on immunocytochemical …

Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine

D Wu, YS Kang, U Bickel, WM Pardridge - Drug metabolism and disposition, 1997 - ASPET
The blood-brain barrier (BBB) permeability to morphine and morphine-6-glucuronide (M6G)
is measured under identical conditions using an intravenous injection method in the rat and …

Regulation of taurine transport at the blood–brain barrier by tumor necrosis factor‐α, taurine and hypertonicity

YS Kang, S Ohtsuki, H Takanaga, M Tomi… - Journal of …, 2002 - Wiley Online Library
Taurine is the abundant sulfur‐containing β‐amino acid in brain where it exerts a
neuroprotective effect. Although it is known that the blood–brain barrier (BBB) mediates taurine …